ABOUT US

Our Technology

logo Vaxdyn blanco-verde

Immunity to combat the most worrisome superbacteria

Decades of research on antibiotic-resistant bacteria led to AcinetoVax, a unique vaccine candidate against multi-drug resistant Acinetobacter baumannii based on inactivated LPS-null A. baumannii cells, protected by an international patent family granted in many jurisdictions, including the USA, Europe, Japan, India, and China.


Vaxdyn created a new proprietary technology by transforming AcinetoVax, a monovalent vaccine candidate, into a technological platform able to deliver multi-valent vaccines for raising immunity against the most worrisome anti-microbial resistant bacteria.


Inactivated multi-antigen whole-cell vaccines based on a LPS (endotoxin)-negative strain of Acinetobacter baumannii

Vaxdyn’s technology aims to address key biological and clinical gaps identified in prior Gram-negative vaccine programs focused on raising immunity against the highly variable surface sugar antigens.

Vaxdyn’s platform is designed for breadth. Cell-bound display of outer membrane proteins presents conserved surface antigens in their native conformation, giving coverage that is not restricted by serotype — a property demonstrated across panels of clinical isolates. Preclinical characterisation shows induction of complement-activating antibodies that mediate bacterial killing, including against hypercapsulated strains, together with antigen-specific T-cell responses.

By displaying OMPs from different bacterial pathogens in the external membrane of the LPS-null A. baumannii cell, Vaxdyn has developed vaccine candidates against Klebsiella pneumoniae, Pseudomonas aeruginosa, or Escherichia coli. These pathogens are among the most critical threats identified by the World Health Organization.

CONTACT

Vaxdyn

Supported by

CONTACT US


Vaxdyn logo
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.